We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+3.85%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$4.25B
AUM Growth
+$636M
Cap. Flow
+$222M
Cap. Flow %
5.22%
Top 10 Hldgs %
17.16%
Holding
2,498
New
632
Increased
436
Reduced
368
Closed
712

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$119M
2
PFE icon
Pfizer
PFE
+$60.7M
3
CRM icon
Salesforce
CRM
+$48.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$20.6M
5
TSLA icon
Tesla
TSLA
+$20.5M

Top Sells

Rank Stock Value
1
DWACU
Digital World Acquisition Corp. Units
DWACU
+$24.6M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$12.6M
3
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$10.1M
4
HLIT icon
Harmonic Inc
HLIT
+$10.1M
5
FTI icon
TechnipFMC
FTI
+$9.92M

Sector Composition

Rank Sector Weight
1 Financials 10.77%
2 Technology 9.75%
3 Healthcare 8.93%
4 Consumer Discretionary 7.52%
5 Real Estate 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGLS
1751
DELISTED
Regulus Therapeutics
RGLS
$39K ﹤0.01%
12,406
– –
RNAC icon
1752
Cartesian Therapeutics
RNAC
$245M
$39K ﹤0.01%
+401
New +$43.1K
MUX icon
1753
McEwen Inc
MUX
$1.18B
$37K ﹤0.01%
+4,210
New +$43.8K
AKBA icon
1754
Akebia Therapeutics
AKBA
$346M
$36K ﹤0.01%
15,823
-59,417
-79% -$162K
DRUG
1755
Bright Minds Biosciences
DRUG
$785M
$35K ﹤0.01%
+2,208
New +$49.1K
LCTX icon
1756
Lineage Cell Therapeutics
LCTX
$284M
$35K ﹤0.01%
+14,258
New +$33.4K
REI icon
1757
Ring Energy
REI
$312M
$35K ﹤0.01%
+15,209
New +$47.1K
SPPI
1758
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$35K ﹤0.01%
+27,556
New +$49.3K
EPZM
1759
DELISTED
Epizyme, Inc
EPZM
$35K ﹤0.01%
+13,948
New +$54.8K
AGEN
1760
Agenus
AGEN
$324M
$33K ﹤0.01%
525
-2,234
-81% -$176K
TBLT
1761
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
$30K ﹤0.01%
8
– –
GERN icon
1762
Geron
GERN
$1.05B
$23K ﹤0.01%
+19,084
New +$27.3K
GNCA
1763
DELISTED
Genocea Biosciences, Inc.
GNCA
$23K ﹤0.01%
19,916
– –
DRMAW icon
1764
Dermata Therapeutics Warrant
DRMAW
$16.3K
$21K ﹤0.01%
12,000
– –
ORTX
1765
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$20K ﹤0.01%
1,493
-4,618
-76% -$76.4K
DFTX
1766
Definium Therapeutics
DFTX
$5.89B
$15K ﹤0.01%
+736
New +$23.5K
CREXW
1767
DELISTED
Creative Realities, Inc. Warrant
CREXW
$15K ﹤0.01%
10,906
-500
-4% -$96
APTO
1768
DELISTED
Aptose Biosciences, Inc.
APTO
$14K ﹤0.01%
23
– –
BRLIR
1769
DELISTED
Brilliant Acquisition Corporation Rights
BRLIR
$13K ﹤0.01%
74,155
– –
ONMDW icon
1770
OneMedNet Corp Warrant
ONMDW
$977K
$12K ﹤0.01%
29,385
– –
BREZR
1771
DELISTED
Breeze Holdings Acquisition Corp. Right
BREZR
$6K ﹤0.01%
28,211
– –
SLNO
1772
DELISTED
Soleno Therapeutics
SLNO
$5K ﹤0.01%
810
– –
A icon
1773
Agilent Technologies
A
$39.9B
– –
-2,513
Closed -$396K
AAL icon
1774
American Airlines Group
AAL
$11B
– –
-10,319
Closed -$198K
AAPL icon
1775
CALL
Apple
AAPL
$4.54T
– –
-181,000
Closed -$25.6M
69 70
71
72 73

Similar funds

MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Boothbay Fund Management's Q4 2021 Portfolio in Review

As of Q4 2021, Boothbay Fund Management held 2,498 positions worth $4.25B, up 18% from $3.61B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boothbay Fund Management deployed $222M of net new capital in Q4 2021, opening 632 new positions and adding to 436 existing holdings. Its largest new stake was Pfizer: 1,225,403 shares worth $72.4M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $12.6M trimmed.

  • Boothbay Fund Management's largest Q4 2021 buy was Pfizer: 1,225,403 shares worth $72.4M.
  • Boothbay Fund Management added most to Amazon in Q4 2021, an estimated $119M increase.
  • Boothbay Fund Management's biggest Q4 2021 reduction was Alphabet (Google) Class C, cutting an estimated $12.6M.
  • Boothbay Fund Management fully exited Digital World Acquisition Corp. Units in Q4 2021, selling an estimated $24.6M.
  • Boothbay Fund Management's ten largest holdings make up 17% of its $4.25B portfolio in Q4 2021.
  • Boothbay Fund Management opened 632 new positions and closed 712 in Q4 2021.
  • Boothbay Fund Management's portfolio value rose 18% quarter-over-quarter to $4.25B.

Based on Boothbay Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.